Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
108M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
10.3M
-
Shares change
-
+7.72M
-
Total reported value, excl. options
-
$277M
-
Value change
-
+$208M
-
Number of buys
-
30
-
Price
-
$26.94
Significant Holders of Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ACRS) as of Q4 2015
31 filings reported holding ACRS - Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share as of Q4 2015.
Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ACRS) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.3M shares
of 108M outstanding shares and own 9.49% of the company stock.
Largest 10 shareholders include FMR LLC (3.8M shares), RA CAPITAL MANAGEMENT, LLC (2.56M shares), FRANKLIN RESOURCES INC (1.65M shares), Rock Springs Capital Management LP (896K shares), Cormorant Asset Management, LLC (648K shares), BlackRock Fund Advisors (155K shares), VANGUARD GROUP INC (150K shares), TURNER INVESTMENTS, L.P. (57.7K shares), NORTHERN TRUST CORP (57.1K shares), and NORGES BANK (50K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.